A Platform for Integrating and Sharing Cancer Stem Cell Data

Advancements in cancer research and treatment have highlighted the need for standardization and sharing of cancer stem cell (CSC) data to facilitate research transparency and to promote collaboration within the scientific community. Although previous applications have attempted to gather and disseminate these data, currently no platform organizes the heterogeneous CSC information into a harmonized project-based framework. The aim of our platform, ReMeDy, is to provide an intelligent informatics solution integrating diverse CSC characteristics, outcomes information, and omics data across clinical, preclinical and in vitro studies. These heterogeneous data streams are organized within a multi-modular framework, subjected to a stringent validation by using standardized ontologies, and stored in a searchable format. To test usefulness of our approach for capturing diverse data related to CSCs, we integrated data from 52 publicly-available CSC projects. We validated the robustness of the platform, by efficiently organizing diverse data elements, and demonstrated its potential for promoting future knowledge discovery driven by aggregation of published data. Next steps include expanding number of uploaded CSC projects and developing additional data visualization tools. The platform is accessible through https://remedy.mssm.edu/.

[1]  G. Hortobagyi,et al.  Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis. , 2012, The Journal of clinical investigation.

[2]  Chiu-Hsieh Hsu,et al.  Colorectal Adenoma Stem-like Cell Populations: Associations with Adenoma Characteristics and Metachronous Colorectal Neoplasia , 2013, Cancer Prevention Research.

[3]  J. Ajani,et al.  Targeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinoma , 2021, Gut.

[4]  W. Liu,et al.  CD133 promotes the self-renewal capacity of thyroid cancer stem cells through activation of glutamate aspartate transporter SLC1A3 expression. , 2019, Biochemical and biophysical research communications.

[5]  M. Seno,et al.  A novel model of liver cancer stem cells developed from induced pluripotent stem cells , 2020, British Journal of Cancer.

[6]  Joseph Finkelstein,et al.  Introducing an Ontology-Driven Pipeline for the Identification of Common Data Elements. , 2020, Studies in health technology and informatics.

[7]  K. Griffith,et al.  Phase II clinical trial of metformin as a cancer stem cell-targeting agent in ovarian cancer. , 2020, JCI insight.

[8]  D. Coppola,et al.  Farnesyl dimethyl chromanol targets colon cancer stem cells and prevents colorectal cancer metastasis , 2021, Scientific Reports.

[9]  J. Choi,et al.  Reprogramming of cancer stem cells into non-tumorigenic cells using stem cell exosomes for cancer therapy. , 2019, Biochemical and biophysical research communications.

[10]  Michael F. Clarke,et al.  Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells , 2009, Cell.

[11]  K. Pachmann,et al.  Influence of adjuvant radiotherapy on circulating epithelial tumor cells and circulating cancer stem cells in primary non-metastatic breast cancer , 2021, Translational oncology.

[12]  Jun-Cheng Guo,et al.  Inhibition of Bone Morphogenetic Protein 2 Suppresses the Stemness Maintenance of Cancer Stem Cells in Hepatocellular Carcinoma via the MAPK/ERK Pathway , 2021, Cancer management and research.

[13]  Sukjoon Yoon,et al.  Targeting a Lipid Desaturation Enzyme, SCD1, Selectively Eliminates Colon Cancer Stem Cells through the Suppression of Wnt and NOTCH Signaling , 2021, Cells.

[14]  D. Arango,et al.  Polymeric micelles targeted against CD44v6 receptor increase niclosamide efficacy against colorectal cancer stem cells and reduce circulating tumor cells in vivo. , 2021, Journal of controlled release : official journal of the Controlled Release Society.

[15]  G. Maira,et al.  Isolation of Cancer Stem Cells from Three Human Glioblastoma Cell Lines: Characterization of Two Selected Clones , 2014, PloS one.

[16]  A. Giuliano,et al.  Most Early Disseminated Cancer Cells Detected in Bone Marrow of Breast Cancer Patients Have a Putative Breast Cancer Stem Cell Phenotype , 2006, Clinical Cancer Research.

[17]  P. Dalerba,et al.  Identification of pancreatic cancer stem cells. , 2006, Cancer research.

[18]  E. Goloni-Bertollo,et al.  Anti-EGFR treatment effects on laryngeal cancer stem cells. , 2021, American journal of translational research.

[19]  M. Todaro,et al.  Cancer Stem Cells Sensitivity Assay (STELLA) in Patients with Advanced Lung and Colorectal Cancer: A Feasibility Study , 2015, PloS one.

[20]  Vasileios Stathias,et al.  LINCS Data Portal 2.0: next generation access point for perturbation-response signatures , 2019, Nucleic Acids Res..

[21]  Martin Götte,et al.  miR-142-3p attenuates breast cancer stem cell characteristics and decreases radioresistance in vitro , 2018, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[22]  Zhonghua Zhao,et al.  Isolation and phenotypic characterization of colorectal cancer stem cells with organ-specific metastatic potential. , 2013, Gastroenterology.

[23]  Anas Elghafari,et al.  Automated Identification of Common Disease-Specific Outcomes for Comparative Effectiveness Research Using ClinicalTrials.gov: Algorithm Development and Validation Study , 2021, JMIR medical informatics.

[24]  Shanshan Wang,et al.  CCL16 maintains stem cell-like properties in breast cancer by activating CCR2/GSK3β/β-catenin/OCT4 axis , 2021, Theranostics.

[25]  M. Cristofanilli,et al.  Cancer stem cells: implications for cancer therapy. , 2014, Oncology.

[26]  Yixuan Hou,et al.  A novel hypoxic long noncoding RNA KB-1980E6.3 maintains breast cancer stem cell stemness via interacting with IGF2BP1 to facilitate c-Myc mRNA stability , 2021, Oncogene.

[27]  Kevin K. Chang,et al.  PI3K/Akt pathway and Nanog maintain cancer stem cells in sarcomas , 2021, Oncogenesis.

[28]  Joseph Finkelstein,et al.  ReMeDy: a platform for integrating and sharing published stem cell research data with a focus on iPSC trials , 2021, Database J. Biol. Databases Curation.

[29]  B. Benassi,et al.  Microsecond Pulsed Electric Fields: An Effective Way to Selectively Target and Radiosensitize Medulloblastoma Cancer Stem Cells. , 2020, International journal of radiation oncology, biology, physics.

[30]  R. Ippoliti,et al.  PPARα-Selective Antagonist GW6471 Inhibits Cell Growth in Breast Cancer Stem Cells Inducing Energy Imbalance and Metabolic Stress , 2021, Biomedicines.

[31]  Xiaobo Zhang,et al.  Requirement of splicing factor hnRNP A2B1 for tumorigenesis of melanoma stem cells , 2021, Stem Cell Research & Therapy.

[32]  Qi Zhou,et al.  SOX4 maintains the stemness of cancer cells via transcriptionally enhancing HDAC1 revealed by comparative proteomics study , 2021, Cell & bioscience.

[33]  Mingwei Chen,et al.  The effect of omentin-1 on the proliferation and apoptosis of colon cancer stem cells and the potential mechanism. , 2019, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[34]  W. Fujibuchi,et al.  First Proposal of Minimum Information About a Cellular Assay for Regenerative Medicine , 2016, Stem cells translational medicine.

[35]  Y. Xiong,et al.  NOTCH-induced aldehyde dehydrogenase 1A1 deacetylation promotes breast cancer stem cells. , 2014, The Journal of clinical investigation.

[36]  N. Maitland,et al.  Prospective identification of tumorigenic prostate cancer stem cells. , 2005, Cancer research.

[37]  Jennifer A. Higgins,et al.  Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy , 2015, Cancer letters.

[38]  K. Kitazato,et al.  Enhanced autophagy in colorectal cancer stem cells does not contribute to radio-resistance , 2016, Oncotarget.

[39]  Ho-Yyoung Lee,et al.  Evodiamine inhibits both stem cell and non-stem-cell populations in human cancer cells by targeting heat shock protein 70 , 2021, Theranostics.

[40]  M. Biffoni,et al.  Control of replication stress and mitosis in colorectal cancer stem cells through the interplay of PARP1, MRE11 and RAD51 , 2021, Cell Death & Differentiation.

[41]  S. Fan,et al.  Significance of CD90+ cancer stem cells in human liver cancer. , 2008, Cancer cell.

[42]  Qiao Li,et al.  Prospective study of the safety and efficacy of a pancreatic cancer stem cell vaccine , 2015, Journal of Cancer Research and Clinical Oncology.

[43]  Y. Mei,et al.  Metallothionein-1G suppresses pancreatic cancer cell stemness by limiting activin A secretion via NF-κB inhibition , 2021, Theranostics.

[44]  R. Bruggmann,et al.  Targeting CD70 with cusatuzumab eliminates acute myeloid leukemia stem cells in patients treated with hypomethylating agents , 2020, Nature Medicine.

[45]  Xie-wan Chen,et al.  Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium , 2015, BMC Cancer.

[46]  Avi Ma'ayan,et al.  Towards Intelligent Integration and Sharing of Stem Cell Research Data. , 2020, Studies in health technology and informatics.

[47]  E. Aronica,et al.  A Selective Competitive Inhibitor of Aldehyde Dehydrogenase 1A3 Hinders Cancer Cell Growth, Invasiveness and Stemness In Vitro , 2021, Cancers.

[48]  Michael F. Clarke,et al.  Phenotypic characterization of human colorectal cancer stem cells , 2007, Proceedings of the National Academy of Sciences.

[49]  N. Bockett,et al.  Cancer Stem Cells in Metastatic Head and Neck Cutaneous Squamous Cell Carcinoma Express Components of the Renin-Angiotensin System , 2021, Cells.

[50]  J. Byun,et al.  Cellular toxicity driven by high-dose vitamin C on normal and cancer stem cells. , 2018, Biochemical and biophysical research communications.

[51]  A. Puisieux,et al.  Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition , 2008, PloS one.

[52]  G. Schneider,et al.  New use of an old drug: inhibition of breast cancer stem cells by benztropine mesylate , 2016, Oncotarget.

[53]  S. Sitasawad,et al.  Keap1-Nrf2 Pathway Regulates ALDH and Contributes to Radioresistance in Breast Cancer Stem Cells , 2021, Cells.

[54]  Chao Cheng,et al.  Single-cell RNA sequencing reveals the impact of chromosomal instability on glioblastoma cancer stem cells , 2019, BMC Medical Genomics.

[55]  Shadan Ali,et al.  Loss of Let-7 Up-Regulates EZH2 in Prostate Cancer Consistent with the Acquisition of Cancer Stem Cell Signatures That Are Attenuated by BR-DIM , 2012, PloS one.

[56]  M. Okada,et al.  Inhibition of the Lipid Droplet–Peroxisome Proliferator-Activated Receptor α Axis Suppresses Cancer Stem Cell Properties , 2021, Genes.

[57]  Joseph Finkelstein,et al.  Informatics Approaches for Harmonized Intelligent Integration of Stem Cell Research , 2020, Stem cells and cloning : advances and applications.